UBS ASSET MANAGEMENT AMERICAS LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$64,237,703,000
+88.8%
1,386,525
-0.6%
0.05%
+84.0%
Q1 2019$34,021,290,000
+41.9%
1,395,459
-17.1%
0.02%
+19.0%
Q4 2018$23,978,333,000
+1.3%
1,682,690
+8.1%
0.02%
+16.7%
Q3 2018$23,669,334,000
-13.3%
1,557,193
-4.3%
0.02%
-14.3%
Q2 2018$27,290,137,000
-15.9%
1,626,349
-18.2%
0.02%
-19.2%
Q1 2018$32,462,389,000
+20.1%
1,989,117
-5.8%
0.03%
+13.0%
Q4 2017$27,039,207,000
+184.0%
2,112,438
+172.9%
0.02%
+155.6%
Q3 2017$9,520,951,000
+44.2%
774,061
-1.9%
0.01%
+50.0%
Q2 2017$6,603,863,000
-9.2%
788,992
-3.0%
0.01%
-14.3%
Q1 2017$7,273,870,000
+96859.1%
813,632
-4.7%
0.01%
-12.5%
Q4 2016$7,502,000
+1251.7%
853,469
+937.3%
0.01%
+700.0%
Q3 2016$555,000
+89.4%
82,2800.0%0.00%
Q2 2016$293,000
+21.1%
82,2800.0%0.00%
Q1 2016$242,000
-44.5%
82,280
-20.3%
0.00%
Q4 2015$436,000
-1.8%
103,278
+6.2%
0.00%
Q3 2015$444,000
-28.8%
97,278
+12.5%
0.00%
-100.0%
Q2 2015$624,000
+43.1%
86,478
+46.3%
0.00%
Q1 2015$436,000
+80.9%
59,096
+16.1%
0.00%
Q4 2014$241,000
+32.4%
50,8960.0%0.00%
Q3 2014$182,000
-21.6%
50,8960.0%0.00%
Q2 2014$232,000
-2.9%
50,8960.0%0.00%
Q1 2014$239,000
-6.3%
50,8960.0%0.00%
Q4 2013$255,000
-40.7%
50,896
-26.2%
0.00%
-100.0%
Q3 2013$430,000
+37.4%
68,9960.0%0.00%
Q2 2013$313,00068,9960.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders